CIK 0001253689 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in E9 · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|
| Revenue (USD) | 10.8 M | |||
| Net income (USD) | -46.7 M | -51.0 M | ||
| Diluted EPS (USD/shares) | -0.59 | -0.89 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-15 | 8-K | 8-K items 8.01 | 2026-10-15 |
| 2026-09-18 | 4 | FORM 4 | 2026-09-16 |
| 2026-09-18 | 4 | FORM 4 | 2026-09-16 |
| 2026-09-18 | 4 | FORM 4 | 2026-09-16 |
| 2026-09-18 | 4 | FORM 4 | 2026-09-16 |
| 2026-09-18 | 4 | FORM 4 | 2026-09-16 |
| 2026-09-18 | 4 | FORM 4 | 2026-09-16 |
| 2026-09-18 | 4 | FORM 4 | 2026-09-16 |
| 2026-09-18 | S-8 | S-8 | |
| 2026-09-17 | 144 | 144 | |
| 2026-09-17 | 144 | 144 | |
| 2026-09-16 | 144 | 144 | |
| 2026-09-16 | 144 | 144 | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-31 | EFFECT | EFFECT items ,, | |
| 2026-07-30 | POS AM | POS AM | |
| 2026-07-30 | 424B3 | 424B3 | |
| 2026-07-30 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-30 | 8-K | 8-K items 2.02,9.01 | 2026-07-30 |
| 2026-07-20 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-07-20 | 4 | OWNERSHIP DOCUMENT | 2026-07-16 |
| 2026-07-15 | 8-K | 8-K items 8.01,9.01 | 2026-07-14 |
| 2026-07-15 | 424B5 | 424B5 | |
| 2026-07-14 | 8-K | 8-K items 2.02 | 2026-07-14 |
| 2026-07-14 | 424B5 | 424B5 |
Forms on file (last 1,000): 4 247, 8-K 113, 3 43, 10-Q 38, SC 13G/A 38, CORRESP 15, SC 13G 15, S-8 14. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CBIO (0.002 USD), /gw/filings/filings?ticker=CBIO&form=8-K, /gw/filings/facts?ticker=CBIO&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange